Shanghai Rightongene (China) Buy Hold or Sell Recommendation

688217 Stock   20.75  0.50  2.35%   
Assuming the 90 days trading horizon and your conservative risk appetite, our recommendation regarding Shanghai Rightongene Biotechnology is 'Strong Sell'. Macroaxis provides Shanghai Rightongene buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding 688217 positions.
  
Check out Shanghai Rightongene Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
In addition, we conduct extensive research on individual companies such as Shanghai and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Shanghai Rightongene Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Execute Shanghai Rightongene Buy or Sell Advice

The Shanghai recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Shanghai Rightongene Biotechnology. Macroaxis does not own or have any residual interests in Shanghai Rightongene Biotechnology or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Shanghai Rightongene's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Shanghai RightongeneBuy Shanghai Rightongene
Strong Sell

Market Performance

OKDetails

Volatility

Somewhat reliableDetails

Hype Condition

StaleDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

Above AverageDetails

Economic Sensitivity

Barely shadows the marketDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

InapplicableDetails
For the selected time horizon Shanghai Rightongene Biotechnology has a Mean Deviation of 3.33, Semi Deviation of 3.87, Standard Deviation of 4.64, Variance of 21.5, Downside Variance of 17.94 and Semi Variance of 15.02
Our trade recommendation module complements current analysts and expert consensus on Shanghai Rightongene. It analyzes the company potential to grow using all fundamental, technical, and market related data available at the time. To make sure Shanghai Rightongene is not overpriced, please validate all Shanghai Rightongene fundamentals, including its current valuation, shares owned by insiders, and the relationship between the operating margin and shares outstanding .

Shanghai Rightongene Trading Alerts and Improvement Suggestions

Shanghai Rightongene appears to be risky and price may revert if volatility continues
Shanghai Rightongene has high likelihood to experience some financial distress in the next 2 years
About 41.0% of the company shares are owned by insiders or employees
Latest headline from news.google.com: How AstraZenecas China fraud was about more than greed - ThinkChina

Shanghai Rightongene Returns Distribution Density

The distribution of Shanghai Rightongene's historical returns is an attempt to chart the uncertainty of Shanghai Rightongene's future price movements. The chart of the probability distribution of Shanghai Rightongene daily returns describes the distribution of returns around its average expected value. We use Shanghai Rightongene Biotechnology price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Shanghai Rightongene returns is essential to provide solid investment advice for Shanghai Rightongene.
Mean Return
0.59
Value At Risk
-5.7
Potential Upside
6.97
Standard Deviation
4.64
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Shanghai Rightongene historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Shanghai Rightongene Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Shanghai Rightongene or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Shanghai Rightongene's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Shanghai stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
0.59
β
Beta against Dow Jones-0.07
σ
Overall volatility
4.86
Ir
Information ratio 0.10

Shanghai Rightongene Volatility Alert

Shanghai Rightongene Biotechnology shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Shanghai Rightongene's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Shanghai Rightongene's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Shanghai Rightongene Fundamentals Vs Peers

Comparing Shanghai Rightongene's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Shanghai Rightongene's direct or indirect competition across all of the common fundamentals between Shanghai Rightongene and the related equities. This way, we can detect undervalued stocks with similar characteristics as Shanghai Rightongene or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Shanghai Rightongene's fundamental indicators could also be used in its relative valuation, which is a method of valuing Shanghai Rightongene by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Shanghai Rightongene to competition
FundamentalsShanghai RightongenePeer Average
Return On Equity-0.0148-0.31
Return On Asset-0.0097-0.14
Profit Margin(0.02) %(1.27) %
Operating Margin0.03 %(5.51) %
Current Valuation987 M16.62 B
Shares Outstanding55.86 M571.82 M
Shares Owned By Insiders40.64 %10.09 %
Shares Owned By Institutions15.60 %39.21 %
Price To Book1.28 X9.51 X
Price To Sales4.65 X11.42 X
Revenue258.21 M9.43 B
Gross Profit257.7 M27.38 B
EBITDA25.94 M3.9 B
Net Income7.93 M570.98 M
Total Debt5.82 M5.32 B
Book Value Per Share14.70 X1.93 K
Cash Flow From Operations45.1 M971.22 M
Earnings Per Share(0.10) X3.12 X
Number Of Employees50118.84 K
Beta0.2-0.15
Market Capitalization1.16 B19.03 B
Total Asset1.04 B29.47 B
Retained Earnings154.03 M9.33 B
Working Capital467.29 M1.48 B
Annual Yield0.01 %
Net Asset1.04 B

Shanghai Rightongene Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Shanghai . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Shanghai Rightongene Buy or Sell Advice

When is the right time to buy or sell Shanghai Rightongene Biotechnology? Buying financial instruments such as Shanghai Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Shanghai Rightongene in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Communication Thematic Idea Now

Communication
Communication Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Communication theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Communication Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Shanghai Stock

Shanghai Rightongene financial ratios help investors to determine whether Shanghai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai Rightongene security.